About Familial primary localized cutaneous amyloidosis
Familial primary localized cutaneous amyloidosis is a rare disease catalogued by Orphanet (ORPHA:353220). It is associated with the OSMR, IL31RA genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Familial primary localized cutaneous amyloidosis trials.
Search ClinicalTrials.gov for "Familial primary localized cutaneous amyloidosis" or filter by Orphanet code ORPHA:353220 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Familial primary localized cutaneous amyloidosis trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Familial primary localized cutaneous amyloidosis. Updated daily.